Boryung Corporation (003850.KS)

10,270.00 +210.00 (+2.09%) At close: 03:30PM KST

Boryung Corporation

Boryeong Building
136 Changgyeonggung- ro Jongno-gu
Seoul 03127
South Korea
82 2 708 8000
https://www.boryung.co.kr

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Jay Kim	Chairman & CEO	N/A	N/A	N/A
Young-Ha Kim	Senior Managing Director, Director of Marketing Division and Director	N/A	N/A	1954
Ho-Young Baek	Director of Operation Support Division and Director	N/A	N/A	1962
Daniel Chang	Chief Executive Officer of Pharma Biz	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in KRW.

Description

Boryung Corporation engages in the manufacture and sale of pharmaceutical products in South Korea and internationally. It offers prescription drugs for hypertension, dyslipidemia, diabetes, central nervous system, and oncology drugs. The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022. Boryung Corporation was founded in 1957 and is headquartered in Seoul, South Korea.

Corporate governance

Boryung Corporation’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.